Division of Gastroenterology, Hepatology and Endoscopy, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Harvard Medical School, Boston, Massachusetts, USA.
J Gastroenterol Hepatol. 2024 Apr;39(4):701-707. doi: 10.1111/jgh.16469. Epub 2024 Jan 7.
BACKGROUND AND AIM: Food/environmental allergens have been associated with eosinophilic esophagitis (EoE); however, the correlation between allergy profiles and disease responsiveness to proton pump inhibitor (PPI) therapy remains unclear. We aimed to assess the association between food/environmental allergies identified on allergen testing and histologic response to PPI in patients with treatment-naive EoE. METHODS: Adults with newly diagnosed EoE who underwent formal testing for food/environmental allergies at a tertiary center were included. All patients underwent twice-daily PPI for 8 weeks with subsequent repeat endoscopy and biopsy to assess histologic response. Patients with <15 eosinophils/hpf on post-PPI mucosal biopsies were classified as responders (PPI-r-EoE), while those with ≥15 eosinophils/hpf were nonresponders (PPI-nr-EoE). RESULTS: Sixty-one patients met inclusion criteria (21 PPI-r-EoE vs 40 PPI-nr-EoE). Demographic, clinical, and endoscopic finding variables were similar between groups. Positive food allergen test was more prevalent among PPI-nr-EoE patients (82.5% vs 42.9%, P = 0.003). On multivariable analysis, positive food allergen testing remained an independent predictor for PPI nonresponse (aOR 0.15, CI: 0.04-0.58, P = 0.0006). Positive environmental allergen testing was highly prevalent, with no significant differences between groups (77.5% vs 95.2%, P = 0.14). However, higher number of positive environmental allergens (23.3% [≥5 allergens] vs 73.3% [<5 allergens], P = 0.003) and specific aeroallergens correlated with PPI-nr-EoE. CONCLUSION: Positive food allergy testing and increased environmental allergens predicted lower likelihood of histologic response to PPI in EoE. Our findings support an allergic phenotype of EoE that may less likely respond to PPI therapy. Formal allergen testing may play a role in therapy selection and tailored management in EoE.
背景与目的:食物/环境过敏原与嗜酸性食管炎(EoE)有关;然而,过敏症候群与质子泵抑制剂(PPI)治疗反应之间的相关性尚不清楚。我们旨在评估在未经治疗的 EoE 患者中,过敏原检测中确定的食物/环境过敏与 PPI 治疗的组织学反应之间的关联。
方法:纳入在三级中心接受食物/环境过敏原正式检测的新诊断为 EoE 的成年人。所有患者接受为期 8 周的每日两次 PPI 治疗,随后进行重复内镜检查和活检以评估组织学反应。PPI 治疗后黏膜活检中嗜酸粒细胞<15/高倍视野(hpf)的患者被归类为应答者(PPI-r-EoE),而嗜酸粒细胞≥15/hpf 的患者为无应答者(PPI-nr-EoE)。
结果:61 名患者符合纳入标准(21 名 PPI-r-EoE 与 40 名 PPI-nr-EoE)。两组间人口统计学、临床和内镜检查结果变量相似。PPI-nr-EoE 患者的食物过敏原检测阳性更为常见(82.5%与 42.9%,P=0.003)。多变量分析显示,食物过敏原检测阳性仍然是 PPI 无应答的独立预测因素(优势比 0.15,95%置信区间:0.04-0.58,P=0.0006)。环境过敏原检测阳性也很常见,两组间无显著差异(77.5%与 95.2%,P=0.14)。然而,更多的环境过敏原阳性(23.3%[≥5 种过敏原]与 73.3%[<5 种过敏原],P=0.003)和特定的气传过敏原与 PPI-nr-EoE 相关。
结论:食物过敏检测阳性和环境过敏原增加预测 EoE 对 PPI 的组织学反应可能性降低。我们的研究结果支持 EoE 的过敏表型,可能对 PPI 治疗反应不佳。过敏原的正式检测可能在 EoE 的治疗选择和个体化管理中发挥作用。
J Clin Gastroenterol. 2024-3-1
Clin Gastroenterol Hepatol. 2010-10-1
Ann Allergy Asthma Immunol. 2017-8
Clin Gastroenterol Hepatol. 2022-5
Clin Gastroenterol Hepatol. 2025-7-16
J Can Assoc Gastroenterol. 2025-3-13
J Clin Gastroenterol. 2024-3-1
Clin Transl Gastroenterol. 2022-11-1
J Pediatr Gastroenterol Nutr. 2022-10-1
J Pediatr Gastroenterol Nutr. 2022-9-1
JAMA. 2021-10-5